Quidel Corp
NASDAQ:QDEL

Watchlist Manager
Quidel Corp Logo
Quidel Corp
NASDAQ:QDEL
Watchlist
Price: 27.36 USD 0.29% Market Closed
Market Cap: $1.9B

Operating Margin

4%
Current
Declining
by 4.2%
vs 3-y average of 8.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4%
=
Operating Income
$108.1m
/
Revenue
$2.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4%
=
Operating Income
$108.1m
/
Revenue
$2.7B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Quidel Corp
NASDAQ:QDEL
1.9B USD
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.4B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.8B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
119.1B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.9B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
KR
HLB Inc
KOSDAQ:028300
8.8T KRW
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
45th
Based on 14 112 companies
45th percentile
4%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Quidel Corp
Glance View

Quidel Corporation, a player in the diagnostic healthcare industry, has steadily navigated the labyrinth of medical innovation, carving out a niche in rapid diagnostic testing. Born out of a mission to streamline the process of disease detection, Quidel has leveraged biotechnology to develop fast, reliable diagnostic solutions that address widespread health issues. This company’s arsenal includes tests for infectious diseases, reproductive health, and autoimmune disorders—each meticulously designed to expedite the diagnostic process while maintaining a stringent commitment to accuracy. By fostering partnerships with healthcare providers and aligning with technological advancements, Quidel has positioned itself as indispensable in the clinic setting, where swift decision-making can significantly impact patient care. At the heart of Quidel's business model is its focus on providing tangible value to both healthcare professionals and patients. The company generates revenue primarily through the sale of its diagnostic products, which are utilized in settings ranging from small clinics to large hospital networks. Quidel's innovative platforms, like the Sofia and Solana systems, are lauded for their efficiency and ease of use, attributes that resonate particularly well in medical environments under pressure to deliver fast and effective results. By effectively converting scientific expertise into practical and user-friendly applications, Quidel not only enhances patient outcomes but also fortifies its financial standing within the competitive landscape of medical diagnostics.

QDEL Intrinsic Value
58.74 USD
Undervaluation 53%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
4%
=
Operating Income
$108.1m
/
Revenue
$2.7B
What is Quidel Corp's current Operating Margin?

The current Operating Margin for Quidel Corp is 4%, which is below its 3-year median of 8.2%.

How has Operating Margin changed over time?

Over the last 3 years, Quidel Corp’s Operating Margin has decreased from 41.2% to 4%. During this period, it reached a low of 1.6% on Dec 29, 2024 and a high of 41.2% on Oct 2, 2022.

Back to Top